Company Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange 11:30:51 2024-04-16 am EDT 5-day change 1st Jan Change
85 CHF -1.73% Intraday chart for Novartis AG -1.59% +0.15%

Business Summary

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:

- oncology (29.9%);

- immunology (17.2%);

- cardiovascular, renal and metabolic diseases (14.1%);

- neuroscience (8.9%).

The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.

At the end of 2023, Novartis AG had 33 production sites worldwide.

Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).

Number of employees: 76,057

Sales per Business

CHF in Million2022Weight2023Weight Delta
Established Brands
30.0 %
- - 12,238 30.0 % -
Oncology
29.9 %
- - 12,213 29.9 % -
Immunology
17.2 %
- - 7,008 17.2 % -
Cardiovascular, Renal and Metabolic
14.1 %
- - 5,743 14.1 % -
Neuroscience
8.9 %
- - 3,633 8.9 % -

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
39.5 %
16,860 34.9 % 16,139 39.5 % -4.28%
Europe
18.9 %
10,469 21.7 % 7,704 18.9 % -26.41%
Asia/Africa/Australasia
9.1 %
4,975 10.3 % 3,700 9.1 % -25.63%
Germany
7.4 %
4,086 8.5 % 3,026 7.4 % -25.94%
China
7.2 %
2,987 6.2 % 2,936 7.2 % -1.73%
Canada and Latin America
7.0 %
3,709 7.7 % 2,854 7.0 % -23.04%
Japan
4.2 %
2,106 4.4 % 1,729 4.2 % -17.90%
France
3.8 %
2,156 4.5 % 1,572 3.8 % -27.09%
Switzerland
2.9 %
926 1.9 % 1,175 2.9 % +26.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 48 04-12-31
Director of Finance/CFO 59 02-12-31
Chief Tech/Sci/R&D Officer 62 22-05-15
Chief Operating Officer 57 17-03-31
Compliance Officer 56 18-11-30
Public Communications Contact 63 03-12-31
Corporate Officer/Principal - 13-07-31
Comptroller/Controller/Auditor 61 22-04-30
Corporate Officer/Principal - -
Human Resources Officer 56 21-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 65 20-02-27
Chairman 68 12-12-31
Director/Board Member 60 23-03-06
Director/Board Member 63 20-02-27
Director/Board Member 59 15-12-31
Director/Board Member 65 12-12-31
Director/Board Member 65 14-12-31
Director/Board Member 68 19-02-27
Director/Board Member 64 17-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,277,477,752 1,866,336,959 ( 81.95 %) 233,443,766 ( 10.25 %) 81.95 %

Shareholders

NameEquities%Valuation
145,083,991 6.625 % 14 073 M CHF
Sandoz Family Foundation
4.070 %
89,135,960 4.070 % 8 646 M CHF
UBS Asset Management Switzerland AG
3.123 %
68,391,910 3.123 % 6 634 M CHF
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.3011 %
6,593,896 0.3011 % 640 M CHF
State Street Global Advisors Ltd.
0.2108 %
4,616,703 0.2108 % 448 M CHF
UBS AG (Investment Management)
0.1782 %
3,902,170 0.1782 % 379 M CHF
La Mondiale SAM (Investment Portfolio)
0.1776 %
3,888,630 0.1776 % 377 M CHF
MFS International (UK) Ltd.
0.1769 %
3,873,030 0.1769 % 376 M CHF
MFS International Singapore Pte. Ltd.
0.1738 %
3,806,964 0.1738 % 369 M CHF
Union Investment Privatfonds GmbH
0.1659 %
3,632,402 0.1659 % 352 M CHF
NameEquities%Valuation
Dodge & Cox
0.6012 %
13,165,538 0.6012 % 1 274 M CHF
PRIMECAP Management Co.
0.5893 %
12,905,697 0.5893 % 1 248 M CHF
Eaton Vance Management
0.3239 %
7,092,253 0.3239 % 686 M CHF
Dimensional Fund Advisors LP
0.2776 %
6,078,175 0.2776 % 588 M CHF
Loomis, Sayles & Co. LP
0.2744 %
6,009,900 0.2744 % 581 M CHF
Fiduciary Trust Company International
0.2701 %
5,915,750 0.2701 % 572 M CHF
U.S. Trust Company of Delaware
0.2401 %
5,258,331 0.2401 % 509 M CHF
Wellington Management Co. LLP
0.2167 %
4,746,599 0.2167 % 459 M CHF
Wells Fargo Bank NA
0.1824 %
3,994,934 0.1824 % 386 M CHF
The Ayco Co. LP
0.1615 %
3,535,902 0.1615 % 342 M CHF
NameEquities%Valuation
LUKB Expert Fondsleitung AG
-
64,694 - 6 M CHF
ATP Fondsmaeglerselskab A/S
-
46,082 - 4 M CHF
Swiss Rock Asset Management AG
-
19,614 - 2 M CHF
Niederer & Partners AG
-
5,300 - 513 818 CHF
JPMorgan Asset Management (China) Co Ltd.
-
2,652 - 257 103 CHF
Liontrust Portfolio Management Ltd.
-
474 - 45 953 CHF

Holdings

NameEquities%Valuation
145,083,991 6.63% 14,073,485,173 $
18,524,209 4.30% 559,613,390 $
17,450,680 70.68% 215,208,068 $
12,307,692 8.15% 25,353,846 $
2,642,762 6.49% 24,947,673 $
1,713,521 4.68% 20,647,928 $
5,908,089 6.12% 18,846,804 $
1,739,130 4.78% 7,095,929 $
413,577 6.30% 5,608,104 $
4,336,759 3.27% 156,123 $

Company contact information

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com
address Novartis AG(NOVN)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Finance/Rental/Leasing
Novartis Finance SA
Finance/Rental/Leasing
Pharmaceuticals: Major
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
94.7 USD
Average target price
107.5 USD
Spread / Average Target
+13.51%
Consensus